Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Blink Health Announces $165M in Financing to Combat High Drug Prices

By Drug Discovery Trends Editor | April 24, 2017

Blink Health announced that it has raised a $90 million Series B led by 8VC, bringing its total financing to $165 million. 8VC also led Blink Health’s $75 million Series A last year and has been a strong supporter since the company’s inception. Blink Health will use the capital to drive innovations that accelerate the company’s mission of making prescription medications affordable and transparently priced for everyone in the U.S.

“Blink Health has quickly emerged as the first company equipped to dismantle the opacity of the prescription drug supply chain. Technology has brought transparency and lower prices to almost every other category of commerce and it is about time that technology shines a light on the unfair prescription drug market,” said Joe Lonsdale, founder of 8VC. “At a time when 30 million Americans remain uninsured and 83% of American workers have an average health plan deductible of over $1,400, Blink Health is solving the nation’s drug pricing epidemic through technology.”

Blink Health’s Series B financing comes on the heels of record growth since launch and accelerated recent demand. Thousands of new users sign up every day on Blink Health’s free website and mobile app, and the company now has over one million monthly active users who are accessing lower prices on the most widely prescribed generic prescriptions. More than 100,000 doctors nationwide, or one in ten prescribers, have patients actively using Blink Health to save on their prescription medications. Blink Health has also announced multiple branded drug programs, including an insulin discount program with pharmaceutical giant Eli Lilly.

“As the nation rethinks healthcare coverage and more consumers face soaring out-of-pocket healthcare expenses, Blink Health is becoming an indispensable tool for millions of Americans to access the medications they need at prices they can afford,” said Blink Health CEO and Co-founder Geoffrey Chaiken.

“Three years ago, we started Blink Health with the mission to leverage technology to lower prescription drug prices for all,” said Blink Health COO and Co-founder Matthew Chaiken, “This financing will fuel the company’s next leap towards achieving that goal.”

 


Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE